FDA Sends Warning Letter to Compounding Firm

The FDA's letter to Wickliffe Pharmaceutical indicates that tests show that some of the firm's drug products are "adulterated and misbranded" under the federal Food, Drug, and Cosmetic Act.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners